BHCM
BHVN icon

Brevan Howard Capital Management’s Biohaven BHVN Stock Holding History

Brevan Howard Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-69,150
Closed -$585K – 2104
2026
Q1 		$585K Buy
+69,150
New +$757K 0.01% 1205
2024
Q3 		– Sell
-17,331
Closed -$602K – 1144
2024
Q2 		$602K Buy
+17,331
New +$685K 0.01% 543

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brevan Howard Capital Management's BHVN Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 69,150 shares — an estimated $585K sold.

Brevan Howard Capital Management first reported a position in BHVN in Q2 2024 and held it in 2 quarters. The position peaked at $602K in Q2 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 69,150 Biohaven shares in Q2 2026, an estimated $585K.
  • Brevan Howard Capital Management first reported a position in Biohaven in Q2 2024 and held it in 2 quarters.
  • Brevan Howard Capital Management's Biohaven position peaked at $602K in Q2 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.